Lack of efficacy of rituximab in refractory sclerodermatous chronic GVHD

Bone Marrow Transplantation

Volumn 47, Issue 5, 2012, Pages 737-738

  George, L ^a   George, B ^a   Gottlieb, D J ^a,b   Hertzberg, M ^a,b   Fernandez Penas P ^a,b  

^a WESTMEAD HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIBODY; CYCLOSPORIN A; ETANERCEPT; ETRETIN; IMATINIB; METHOTREXATE; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID; PREDNISOLONE; RAPAMYCIN; RITUXIMAB; ROMIDEPSIN; TACROLIMUS;

ADULT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE EXACERBATION; DRUG EFFICACY; GRAFT VERSUS HOST REACTION; HUMAN; LETTER; MALE; MEDICAL RECORD; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PUVA; REFRACTORY SCLERODERMATOUS CHRONIC GRAFT VERSUS HOST REACTION; RETROSPECTIVE STUDY; TREATMENT RESPONSE; ULTRAVIOLET B RADIATION;

ADULT; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; DRUG RESISTANCE; GRAFT VS HOST DISEASE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SCLERODERMA, LOCALIZED; SKIN DISEASES;

EID: 84860884764     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2011.150     Document Type: Letter

References (5)

1. Kharfan-Dabaja MA, Mhaskar AR, Djulbegovic B, Cutler C, Mohty M, Kumar A. Efficacy of rituximab in the setting of steroid-refractory chronic graft-versus-host disease: a systematic review and meta-analysis. Biol Blood Marrow Transplant 2009; 15: 1005-1013.
2. Zaja F, Bacigalupo A, Patriarca F, Stanzani M, Van Lint MT, Fili C et al. Treatment of refractory chronic GVHD with rituximab: a GITMO study. Bone Marrow Transplant 2007; 40: 273-277.
3. Okamoto M, Okano A, Akamatsu S, Ashihara E, Inaba T, Takenaka H et al. Rituximab is effective for steroid-refractory sclerodermatous chronic graft-versus-host disease. Leukemia 2006; 20: 172-173.
4. Cutler C, Miklos D, Kim HT, Treister N, Woo SB, Bienfang D et al. Rituximab for steroid-refractory chronic graft-versus-host disease. Blood 2006; 108: 756-762.
5. Ratanatharathorn V, Ayash L, Reynolds C, Silver S, Reddy P, Becker M et al. Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody. Biol Blood Marrow Transplant 2003; 9: 505-511.